GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Oriola Corp (FRA:O5O) » Definitions » Research & Development

Oriola (FRA:O5O) Research & Development : €0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Oriola Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Oriola's Research & Development for the three months ended in Mar. 2024 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was €0 Mil.

Oriola Research & Development Historical Data

The historical data trend for Oriola's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oriola Research & Development Chart

Oriola Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Oriola Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Oriola Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oriola  (FRA:O5O) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Oriola Research & Development Related Terms

Thank you for viewing the detailed overview of Oriola's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Oriola (FRA:O5O) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Oriola Corp (FRA:O5O) » Definitions » Research & Development
Comparable Companies
OSTO:SEB A OSTO:HOFI OSTO:SWED A OSTO:SHB A OSTO:TFBANK OSTO:AZA WBA BSP:RADL3 SHSE:603939 HKSE:00241 TSE:3088 SAU:4164 SHSE:600998 JSE:CLS TSE:3349 TSE:9989 TSE:3391 TSE:3141 TSE:7649 SHSE:603883
Traded in Other Exchanges
OKDBV:Finland OKDAV:Finland
Address
Orionintie 5, P.O. Box 8, Espoo, FIN, FI-02200
Website
https://www.oriola.com
Oriola Corp is a health and wellbeing company operating in Nordic countries. It offers services such as the distribution of pharmaceuticals and other health and well-being products, expert services, and dose dispensing. Oriola's operations are divided into three business areas namely, Consumer, Pharma, and Retail.

Oriola (FRA:O5O) Headlines

No Headlines